Company Filing History:

3 out of 4,447

Eli Lilly and Company

patents

1 out of 164

Amylin Pharmaceuticals, Inc.

patents

1 out of 38

Astrazeneca Pharmaceuticals LP

patents

where one patent can have more than one assignee

Years Active: 2007-2013

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8501693 - Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen (2013-08-06),

2. 7989585 - Chronic treatment regimen using glucagon-like insulinotropic peptides (2011-08-02),

3. 7259233 - Chronic treatment regimen using glucagon-like insulinotropic peptides (2007-08-21),

4. 7179788 - Biphasic mixtures of GLP-1 and insulin (2007-02-20),

Title: The Inventor Michael Trautmann from Hamburg

Introduction: Michael Trautmann is a renowned inventor based in Hamburg, Germany, known for his groundbreaking innovations in various fields.

Latest Patents: Michael Trautmann holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Michael Trautmann has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Michael Trautmann has collaborated with top universities, research institutions, and multinational corporations to bring his inventions to life and drive forward technological advancements.

Conclusion: Michael Trautmann's passion for innovation and his dedication to pushing the boundaries of what is possible make him a key figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com